The "mRNA Platform - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA Platform was estimated at US$152.0 Billion in 2024 and is ...

BioNTech reaches agreement to get a non-exclusive license for mRNA-based Covid-19 and/or influenza products and resolve patent litigation with CureVac & GSK: Mainz, Germany Monday ...

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...

Lack of mRNA funding could pose a national security risk; CureVac, GSK settle mRNA suit against Pfizer, BioNTech; Gilead confident in HIV prevention drug prospects.

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...

GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...

GSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...

A top official at the Department of Health and Human Services (HHS) has been fired, igniting a firestorm of controversy and ...

Adding to the mixed messages on the consumer, Delivery firm Instacart posted its strongest order growth since 2022 for a second straight quarter and beat earnings estimates for the current period.

Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.

A 15-year-old girl asked a 44-year-old man to drive her away from her home in Norway, according to an Orangeburg County Sheriff’s Office warrant.